scispace - formally typeset
J

Johannes A. Kragten

Publications -  6
Citations -  6513

Johannes A. Kragten is an academic researcher. The author has contributed to research in topics: Internal medicine & Hazard ratio. The author has an hindex of 4, co-authored 4 publications receiving 5901 citations.

Papers
More filters
Journal ArticleDOI

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Åke Hjalmarson, +350 more
- 12 Jun 1999 - 
TL;DR: Metoprolol controlled release/extended release (CR/XL) once daily in addition to standard therapy improved survival and the drug was well tolerated.
Journal ArticleDOI

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, +798 more
- 27 Oct 2018 - 
TL;DR: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events, and evidence-based glucagon-like peptide 1 receptor agonists should be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events.
Journal ArticleDOI

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Menno V. Huisman, +1027 more
TL;DR: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombinotic t...
Journal ArticleDOI

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Agnieszka Kotalczyk, +899 more
TL;DR: In this paper , the effectiveness and safety of NOACs in patients with newly diagnosed atrial fibrillation (AF) were compared on the GLORIA-AF Phase III registry.